Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198047 | 0.80 | TSHR (0.57) | ACP3TSHRMEN1KMT2ATDP1 | |
| SCHEMBL6503600 | 0.80 | TSHR (0.57) | ACP3TSHRMEN1KMT2ATDP1 | |
| SCHEMBL10616896 | 0.80 | ACP3 (0.47) | ACP3TSHRMEN1KMT2ALMNA | |
| SCHEMBL6691199 | 0.80 | TSHR (0.57) | ACP3TSHRMEN1KMT2ATDP1 | |
| SCHEMBL7207205 | 0.79 | TSHR (0.38) | TSHRIDO1 | |
| SCHEMBL27516064 | 0.78 | CYP3A4 (0.44) | TSHRTDP1LMNASLC6A2SLC6A4 | |
| SCHEMBL6966592 | 0.78 | ADRB1 (0.48) | TSHRLMNAADRB2ADRB1ADRB3 | |
| SCHEMBL11142983 | 0.77 | PTGS1 (0.44) | MEN1KMT2ALMNAADRB3ALDH1A1 | |
| SCHEMBL424623 | 0.76 | ACP3 (0.50) | ACP3TSHRMEN1KMT2ALMNA | |
| SCHEMBL6225449 | 0.76 | ACP3 (0.50) | ACP3TSHRMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119570160-A | High-impact material prepared from recycled polypropylene and preparation method thereof | 肇庆市合亚科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119570160-B | High-impact material prepared from recycled polypropylene and preparation method thereof | 肇庆市合亚科技有限公司 | 2025-08-22 | — | — | CN | disclosed |
| CN-119570160-A | High-impact material prepared from recycled polypropylene and preparation method thereof | 肇庆市合亚科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119570160-A | High-impact material prepared from recycled polypropylene and preparation method thereof | 肇庆市合亚科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-1149092-B1 | 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6605730-B2 | 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula | NIHON BAYER AGROCHEM K.K. (JP) | 2003-08-12 | — | — | US | disclosed |
| US-20030028034-A1 | Nematicidal pyrazoles | WADA KATSUAKI (JP) | 2003-02-06 | — | — | US | disclosed |
| CN-1331689-A | 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles | HOFFMANN LA ROCHE (CH) | 2002-01-16 | — | — | CN | disclosed |
| US-6313310-B1 | JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT | HOFFMANN-LA ROCHE INC. | 2001-11-06 | — | — | US | disclosed |
| EP-1149092-A2 | 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-6310049-B1 | 3-(2-THIENYL),5-(SUBSTITUTED PHENYL)-1H-PYRAZOLES AND 3-(SUBSTITUTED PHENYL),5-(2-THIENYL)-1H-PYRAZOLES OF GIVEN FORMULA; ANTHELMINTICS | NIHON BAYER AGROCHEM K.K. (JP) | 2001-10-30 | — | — | US | disclosed |
| WO-2000035906-A2 | 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| US-4568749-A | Certain 5-aryl-2-[(4-aryl)-4-hydroxybutyn-2-yl]-1,2,3,4-γ-carbolines | PFIZER INC. (US) | 1986-02-04 | — | — | US | disclosed |
| US-4515768-A | STABILIZER AGAINST THERMAL DECOMPOSITION | AIRWICK INDUSTRIES, INC. (US) | 1985-05-07 | — | — | US | disclosed |
| US-4510308-A | Process for preparing carboline derivatives | PFIZER INC. (US) | 1985-04-09 | — | — | US | disclosed |
| EP-0036385-B1 | INSECTICIDAL VAPOUR-EMITTING COMPOSITIONS ON THE BASIS OF PYRETHRINOIDS | Airwick AG (CH) | 1984-05-02 | — | — | EP | disclosed |
| US-4439415-A | PYRETHRINOID AND ABSORPTIVE SUBSTRATE | AIRWICK INDUSTRIES, INC. (US) | 1984-03-27 | — | — | US | disclosed |
| EP-0036385-A2 | Insecticidal vapour-emitting compositions on the basis of pyrethrinoids | Airwick AG (CH) | 1981-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030028034-A1 | Nematicidal pyrazoles | CBR3, CBR1, CCR4 | ACP3 4172/4885TSHR 1691/4885MEN1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.